Sofia Harumi Lopes Nishikawa

Ms. Sofia Harumi Lopes Nishikawa

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2009 in Experimental Cell Research
Verified
Journal Article
Open access
NKNobuyuki Kondo
Nobuyuki Kondo
MOMinetaro Ogawa
Minetaro Ogawa
HWHiromi Wada
Hiromi Wada
Sofia Harumi Lopes NishikawaSofia Harumi Lopes Nishikawa
Sofia Harumi Lopes Nishikawa
The cell-to-cell junction of endothelial cells (ECs) regulates the fence function of the vascular system. Previously we showed that ECs derived from embryonic stem cells (i.e., EECs) develop to form stable endothelial sheets in monolayer cultures. Immunohistochemical analysis revealed that these EECs formed intercellular junctions with the help of vascular endothelial cadherin (VECD) and claudin-5. In this study, we investigated the response of EC sheets to stimuli that are known to increase vascular permeability. While vascular endothelial growth factor A and histamine disrupted the EC junction by enhancing contraction of EECs, thrombin affected specifically the localization of claudin-5 at this junction. We could not detect any significant effect of thrombin on the localization of VECD. Concerning thrombin receptors, EECs expressed protease-activated receptor 1 (PAR1) but not PAR4. Consistent with this expression pattern, PAR1 agonists eliminated claudin-5 as effectively as thrombin itself. This is the first report to show that claudin-5 can be disassembled from the EC junction in a signal-dependent manner and to suggest that claudin-5 mobilization is a cause of PAR1-induced increase in vascular permeability.

1 July 2007 in Blood
Verified
Journal Article
Open access
PDF file
YTYosuke Tanaka
Yosuke Tanaka
TETakumi Era
Takumi Era
Sofia Harumi Lopes NishikawaSofia Harumi Lopes Nishikawa
Sofia Harumi Lopes Nishikawa
SKShin Kawamata
Shin Kawamata
Nanog is a key molecule involved in the maintenance of the self-renewal of undifferentiated embryonic stem (ES) cells. In this work we investigate whether Nanog can enhance self-renewal in hematopoietic stem cells. Contrary to our expectation, no positive effect of Nanog transduction was detected in bone marrow reconstitution assays. However, recipients of Nanog-transduced (Nanog) hematopoietic stem cells (HSCs) invariantly develop a unique disorder typified by an atrophic thymus occupied by Nanog-expressing γδT-cell receptor–positive (TCR+) cells (Nanog T cells). All thymi are eventually occupied by Nanog T cells with CD25+CD44+ surface phenotype that home selectively to the thymus on transfer and suppress normal thymocyte development, which is partly ascribed to destruction of the microenvironment in the thymus cortex. Moreover, this initial disorder invariantly develops to a lymphoproliferative disorder, in which Nanog T cells undergo unlimited proliferation in the peripheral lymphoid tissues and eventually kill the host. This invariable end result suggests that Nanog is a candidate oncogene for γδT-cell malignancy.

1 February 1993 in Immunology Letters
Verified
Journal Article
Closed access
HOHisato Ohno
Hisato Ohno
MOMinetaro Ogawa
Minetaro Ogawa
SNSatomi Nishikawa
Satomi Nishikawa
SHShin-Ichi Hayashi
Shin-Ichi Hayashi
TKTakahiro Kunisada
Takahiro Kunisada
Sofia Harumi Lopes NishikawaSofia Harumi Lopes Nishikawa
Sofia Harumi Lopes Nishikawa

1 September 1993 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
YYY Yoshiyama
Y Yoshiyama
Sofia Harumi Lopes NishikawaSofia Harumi Lopes Nishikawa
Sofia Harumi Lopes Nishikawa
TST Sugiyama
T Sugiyama
TKT Kobayashi
T Kobayashi
HSH Shimada
H Shimada
SNS Nakano
S Nakano
Nephrotoxicity was more marked in rats receiving isepamicin at midlight than at middark. And, the once-daily administration at middark induced a lesser degree of nephrotoxicity than the twice-daily injection, which indicates that the once-daily treatment therapy may have potential value in the clinical use of aminoglycosides.

30 July 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
MRMarcelo Felisberto dos Reis
Marcelo Felisberto dos Reis
NLNycolas Levy-Pereira
Nycolas Levy-Pereira
NRNathalia Raissa de Alcântara Rocha
Nathalia Raissa de Alcântara Rocha
TLTalita Maria Lazaro
Talita Maria Lazaro
MFMarisa Matias de França
Marisa Matias de França
RSRicardo Luiz Moro De Sousa
Ricardo Luiz Moro De Sousa
Studies on plant extracts as growth promoters and immunostimulants have shown promising results. However, their effects on fish health and growth remain unclear. This study evaluated the in vitro and in vivo effects of Eucalyptus globulus pyroligneous extract (PE) on Nile tilapia. In vitro, minimal inhibitory and bactericidal concentration (MIC and MBC) and antibiogram analyses showed that PE could eliminate key bacterial strains affecting fish and human health, but only if its volatile components were preserved. In vivo, Oreochromis niloticus juveniles were fed diets containing 0.5% and 1% PE. We assessed fish hematology, phagocytosis, survival against Streptococcus agalactiae, and growth parameters. Fish fed 1% PE had lower erythrocyte and lymphocyte counts but higher neutrophil levels than controls. Their phagocytic capacity was significantly enhanced compared to both the control and 0.5% groups. However, the 0.5% PE group had a higher phagocytic index than both the control and 1% groups. No protection against S. agalactiae or significant effects on growth were observed. In conclusion, distilled E. globulus PE shows potential as an immunostimulant for fish. However, further studies are needed to preserve its volatile compounds and optimize its use in aquaculture.